{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:47:23Z","timestamp":1771627643140,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,3,31]],"date-time":"2005-03-31T00:00:00Z","timestamp":1112227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,3,31]],"date-time":"2005-03-31T00:00:00Z","timestamp":1112227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1038\/sj.leu.2403712","type":"journal-article","created":{"date-parts":[[2005,3,31]],"date-time":"2005-03-31T10:52:48Z","timestamp":1112266368000},"page":"1005-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1"],"prefix":"10.1038","volume":"19","author":[{"given":"C","family":"Walz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Chase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Schoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Weisser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Hochhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Schmitt-Gr\u00e4ff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Hehlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N C P","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,3,31]]},"reference":[{"key":"BF2403712_CR1","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","volume":"100","author":"JW Vardiman","year":"2002","unstructured":"Vardiman JW, Harris NL, Brunning RD . The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292\u20132302.","journal-title":"Blood"},{"key":"BF2403712_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000046639","volume":"107","author":"D Macdonald","year":"2002","unstructured":"Macdonald D, Reiter A, Cross NC . The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol 2002; 107: 101\u2013107.","journal-title":"Acta Haematol"},{"key":"BF2403712_CR3","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa025217","volume":"348","author":"J Cools","year":"2003","unstructured":"Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003; 348: 1201\u20131214.","journal-title":"N Engl J Med"},{"key":"BF2403712_CR4","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.leu.2402556","volume":"16","author":"NC Cross","year":"2002","unstructured":"Cross NC, Reiter A . Tyrosine kinase fusion genes in chronic myeloproliferative diseases. Leukemia 2002; 16: 1207\u20131212.","journal-title":"Leukemia"},{"key":"BF2403712_CR5","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1182\/blood.V92.5.1735","volume":"92","author":"A Reiter","year":"1998","unstructured":"Reiter A, Sohal J, Kulkarni S, Chase A, Macdonald DH, Aguiar RC et al. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood 1998; 92: 1735\u20131742.","journal-title":"Blood"},{"key":"BF2403712_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1365-2141.1995.tb03392.x","volume":"90","author":"JG Zhang","year":"1995","unstructured":"Zhang JG, Goldman JM, Cross NC . Characterization of genomic BCR-ABL breakpoints in chronic myeloid leukaemia by PCR. Br J Haematol 1995; 90: 138\u2013146.","journal-title":"Br J Haematol"},{"key":"BF2403712_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/gcc.1177","volume":"32","author":"J Sohal","year":"2001","unstructured":"Sohal J, Chase A, Mould S, Corcoran M, Oscier D, Iqbal S et al. Identification of four new translocations involving FGFR1 in myeloid disorders. Genes Chromosomes Cancer 2001; 32: 155\u2013163.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2403712_CR8","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1182\/blood.V98.13.3778","volume":"98","author":"A Demiroglu","year":"2001","unstructured":"Demiroglu A, Steer EJ, Heath C, Taylor K, Bentley M, Allen SL et al. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood 2001; 98: 3778\u20133783.","journal-title":"Blood"},{"key":"BF2403712_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/ng0198-84","volume":"18","author":"S Xiao","year":"1998","unstructured":"Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES et al. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia\/lymphoma syndrome. Nat Genet 1998; 18: 84\u201387.","journal-title":"Nat Genet"},{"key":"BF2403712_CR10","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1073\/pnas.95.10.5712","volume":"95","author":"C Popovici","year":"1998","unstructured":"Popovici C, Adelaide J, Ollendorff V, Chaffanet M, Guasch G, Jacrot M et al. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13). Proc Natl Acad Sci USA 1998; 95: 5712\u20135717.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403712_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/hmg\/7.4.637","volume":"7","author":"D Smedley","year":"1998","unstructured":"Smedley D, Hamoudi R, Clark J, Warren W, Abdul-Rauf M, Somers G et al. The t(8;13)(p11;q11\u201312) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP. Hum Mol Genet 1998; 7: 637\u2013642.","journal-title":"Hum Mol Genet"},{"key":"BF2403712_CR12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood.V93.4.1381","volume":"93","author":"C Popovici","year":"1999","unstructured":"Popovici C, Zhang B, Gregoire MJ, Jonveaux P, Lafage-Pochitaloff M, Birnbaum D et al. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood 1999; 93: 1381\u20131389.","journal-title":"Blood"},{"key":"BF2403712_CR13","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.V95.5.1788.005k15_1788_1796","volume":"95","author":"G Guasch","year":"2000","unstructured":"Guasch G, Mack GJ, Popovici C, Dastugue N, Birnbaum D, Rattner JB et al. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). Blood 2000; 95: 1788\u20131796.","journal-title":"Blood"},{"key":"BF2403712_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/gcc.1195","volume":"32","author":"T Fioretos","year":"2001","unstructured":"Fioretos T, Panagopoulos I, Lassen C, Swedin A, Billstrom R, Isaksson M et al. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL. Genes Chromosomes Cancer 2001; 32: 302\u2013310.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2403712_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/sj.thj.6200201","volume":"3","author":"M Pini","year":"2002","unstructured":"Pini M, Gottardi E, Scaravaglio P, Giugliano E, Libener R, Baraldi A et al. A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p. Hematol J 2002; 3: 315\u2013316.","journal-title":"Hematol J"},{"key":"BF2403712_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1182\/blood-2002-02-0577","volume":"101","author":"G Guasch","year":"2003","unstructured":"Guasch G, Popovici C, Mugneret F, Chaffanet M, Pontarotti P, Birnbaum D et al. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3). Blood 2003; 101: 286\u2013288.","journal-title":"Blood"},{"key":"BF2403712_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/gcc.20023","volume":"40","author":"EK Grand","year":"2004","unstructured":"Grand EK, Grand FH, Chase AJ, Ross FM, Corcoran M, Oscier DG et al. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in the 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer 2004; 40: 78\u201383.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2403712_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1006\/bbrc.2000.2377","volume":"270","author":"T Furusawa","year":"2000","unstructured":"Furusawa T, Ikawa S, Yanai N, Obinata M . Isolation of a novel PDZ-containing myosin from hematopoietic supportive bone marrow stromal cell lines. Biochem Biophys Res Commun 2000; 270: 67\u201375.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF2403712_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/jb\/mvg053","volume":"133","author":"K Mori","year":"2003","unstructured":"Mori K, Furusawa T, Okubo T, Inoue T, Ikawa S, Yanai N et al. Genome structure and differential expression of two isoforms of a novel PDZ-containing myosin (MysPDZ) (Myo18A). J Biochem (Tokyo) 2003; 133: 405\u2013413.","journal-title":"J Biochem (Tokyo)"},{"issue":"Part 1","key":"BF2403712_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1042\/bj20031978","volume":"380","author":"M Cross","year":"2004","unstructured":"Cross M, Csar XF, Wilson NJ, Manes G, Addona TA, Marks DC et al. A novel 110\u2009kDa form of myosin XVIIIA (MysPDZ) is tyrosine-phosphorylated after colony-stimulating factor-1 receptor signalling. Biochem J 2004; 380 (Part 1): 243\u2013253.","journal-title":"Biochem J"},{"key":"BF2403712_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00062752-200301000-00007","volume":"10","author":"E Anastasiadou","year":"2003","unstructured":"Anastasiadou E, Schwaller J . Role of constitutively activated protein tyrosine kinases in malignant myeloproliferative disorders: an update. Curr Opin Hematol 2003; 10: 40\u201348.","journal-title":"Curr Opin Hematol"},{"issue":"Suppl 3","key":"BF2403712_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1053\/shem.2002.36921","volume":"39","author":"DG Gilliland","year":"2002","unstructured":"Gilliland DG . Molecular genetics of human leukemias: new insights into therapy. Semin Hematol 2002; 39 (Suppl 3): 6\u201311.","journal-title":"Semin Hematol"},{"key":"BF2403712_CR23","doi-asserted-by":"publisher","first-page":"14479","DOI":"10.1073\/pnas.0404438101","volume":"101","author":"J Chen","year":"2004","unstructured":"Chen J, Deangelo DJ, Kutok JL, Williams IR, Lee BH, Wadleigh M et al. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc Natl Acad Sci USA 2004; 101: 14479\u201314484.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403712.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403712","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403712.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:32:46Z","timestamp":1648776766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,31]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6,1]]}},"alternative-id":["BF2403712"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403712","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,31]]},"assertion":[{"value":"22 November 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}